Evaluation of Eluxadoline Effect on Cardiac Repolarization.

Clin Pharmacol Drug Dev · 2018 · PMC6175186 · PMID 29659201

Europe PMC DOI

hedged sentence

0.0580

closest p · 1.2× alpha

0.0580

boldest claim

The sentences

borderline significantP = .058so close (0.05 < p ≤ 0.1)

Sex Analysis The effect of eluxadoline on QTcI intervals was inconsistent between men and women, with a single significant sex‐by‐treatment interaction at 15 hours following dosing ( P = .029) and 1 borderline significant interaction at 5 hours following dosing ( P = .058).

also in 11,409 other papers

Quoted from the open-access full text in Europe PMC under the licence the publisher applied. The sentence is reproduced exactly as published; the emphasis is ours.